lncRNA LINC02323 predicts adverse neoadjuvant chemotherapy outcomes of gastric cancer patients and regulates cell sensitivity to 5-fluorouracil by negatively modulating miR-139-3p

Zexu Chen Xiaodong Zhang Zhentao Li Haihan Zhang Zhuangmei Wang a Department of General Surgery,Shanghai Pudong New Area People's Hospital,Shanghai,Chinab Department of Gastroenterology,Nanjing LuHe People's Hospital,Nanjing,Jiangsu,Chinac Department of Gastroenterology,Xuzhou Municipal Hospital Affiliated to XuZhou Medical University,Xuzhou,Jiangsu,China
DOI: https://doi.org/10.1080/07853890.2024.2424513
IF: 5.348
2024-11-08
Annals of Medicine
Abstract:Background/Objective Drug resistance is a challenging problem in the clinical chemotherapy of gastric cancer. Identification of predictive biomarkers for chemotherapy outcomes could improve therapeutic efficacy and patient prognosis. This study aimed to assess the significance of long non-coding RNA (lncRNA) LINC02323 in gastric cancer progression and neoadjuvant chemotherapy and to explore its potential regulatory mechanism.
medicine, general & internal
What problem does this paper attempt to address?